Clinical Trial Update: Utilization of Fixed Combination (Budesonide/Formoterol and Salmeterol/Fluticasone and Beclomethasone/Formoterol) in Treatment of Asthma Patients

View source ↗

Summary

An update on a completed clinical trial evaluating the use of fixed-dose inhaled corticosteroid/long-acting beta-agonist combinations in asthma treatment. The t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Beclomethasone/Formoterol (beclomethasone formoterol)
• Seretide (fluticasone propionate/salmeterol)
• Symbicort (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Status: COMPLETED